Related references
Note: Only part of the references are listed.Chryso-lactams:Gold(I) derivatives of ampicillin with specific activity against Gram-positive pathogens
Mathieu Michaut et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Antibacterial and antivirulence activities of auranofin against Clostridium difficile
Ahmed AbdelKhalek et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Will morphing boron-based inhibitors beat the β-lactamases?
Alen Krajnc et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
Synthesis and Structure-Activity Relationship Study of Antimicrobial Auranofin against ESKAPE Pathogens
Bin Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
Ronald Domalaon et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Ruthenium-Catalyzed Azide Alkyne Cycloaddition Reaction: Scope, Mechanism, and Applications
Johan R. Johansson et al.
CHEMICAL REVIEWS (2016)
Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens
Shankar Thangamani et al.
SCIENTIFIC REPORTS (2016)
Antibacterial properties and atomic resolution X-ray complex crystal structure of a ruthenocene conjugated β-lactam antibiotic
Eric M. Lewandowski et al.
CHEMICAL COMMUNICATIONS (2015)
Small organometallic compounds as antibacterial agents
Malay Patra et al.
DALTON TRANSACTIONS (2012)
The Rheumatoid Arthritis Drug Auranofin Has Significant in Vitro Activity in MCL and DLCL and Is Synergistic with a Glutathione Depleting Agent
Jolanta Skalska et al.
BLOOD (2012)
Coevolution: Mankind and microbes
Lester A. Mitscher
JOURNAL OF NATURAL PRODUCTS (2008)
Ruthenium-catalyzed azide-alkyne cycloaddition: Scope and mechanism
Brant C. Boren et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Carbon-gold bond formation through [3+2] cycloaddition reactions of gold(I) azides and terminal alkynes
David V. Partyka et al.
ORGANOMETALLICS (2007)
Share Paper
